revealed that genetic ablation or pharmacologic manipulation of NRP1 expression in microglia or bone marrow-derived macrophages arrested glioma progression and increased antitumorigenic polarization in these cells (19). The gene discussed is NRP1; the disease is central nervous system cancer.